“…The high seroprevalence of CMV that was discovered suggests that there is a wide circulation of the virus in the Bahia State; however, this prevalence is consistent with other Brazilian, as well as worldwide, studies. For example, serological surveys among blood donors showed the following regional CMV seroprevalences: 87.9% in Brazil [Matos et al, 2010], 93.2% in Ghana [Adjei et al, 2006], 95% in India [Kothari et al, 2002], 97.2% in Turkey [Mutlu et al, 2008], 92% in Nigeria [Alao et al, 2008], 97.14% in Tunisia [Gargouri et al, 2000], 69.8% in Spain [Rojo et al, 1992], and between 35.5% and 45.8% in the USA [Hecker et al, 2004; Boeke et al, 2008].…”